ARTICLE | Distillery Therapeutics
Cancer
November 15, 2016 5:40 PM UTC
Cell culture and mouse studies suggest inhibiting DDX3 in combination with radiation treatment could help treat prostate cancer. In DDX3-expressing human prostate cancer cell lines, shRNA targeting DD...
BCIQ Company Profiles
BCIQ Target Profiles